Citadel Advisors’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,580
| Closed | -$147K | – | 6979 |
|
|
2025
Q1 | $147K | Buy |
+26,580
| New | +$147K | ﹤0.01% | 5007 |
|
|
2022
Q2 | – | Sell |
-10,133
| Closed | -$99K | – | 6903 |
|
|
2022
Q1 | $99K | Sell |
10,133
-242,299
| -96% | -$2.37M | ﹤0.01% | 5658 |
|
|
2021
Q4 | $2.49M | Sell |
252,432
-2,209
| -0.9% | -$21.8K | ﹤0.01% | 2817 |
|
|
2021
Q3 | $2.53M | Sell |
254,641
-307,682
| -55% | -$3.06M | ﹤0.01% | 2746 |
|
|
2021
Q2 | $5.49M | Buy |
562,323
+1,279
| +0.2% | +$12.5K | ﹤0.01% | 2041 |
|
|
2021
Q1 | $5.42M | Buy |
+561,044
| New | +$5.42M | ﹤0.01% | 2001 |
|